Journey Medical Corporation (DERM)
Journey Medical Corporation operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Scottsdale, AZ, US. The stock last traded at $6.43, up 1.75% on the session, giving a market capitalisation of $177.0M. On trailing twelve-month figures it carries a trailing P/E of -17.11, a net margin of -14.8%. Its beta of 1.08 implies it has historically moved more than the broad market.
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.
Journey Medical Corporation is most often compared with the following Healthcare names: